CSF-1 inhibits senescence and scarring in injured prematurely-aged kidneys by reversing senescence-induced loss of macrophage MerTK

Authors:
  • MRMaximillian Reck
    Maximillian Reck
  • RCRoss A. Campbell
    Ross A. Campbell
  • DBDavid P. Baird
    David P. Baird
  • MPMaya Pruzek
    Maya Pruzek
  • TSTamara Sneperger
    Tamara Sneperger
  • HPHimath Perera
    Himath Perera
  • PJPiotr P. Janas
    Piotr P. Janas
  • MDMarie-Helena Docherty
    Marie-Helena Docherty
  • TMTilly Mason
    Tilly Mason
  • CCCarolynn Cairns
    Carolynn Cairns
  • DFDavid A. Ferenbach
    David A. Ferenbach

Abstract
Renal injury in aged mice leads to accumulation of senescent cells (SCs) that inhibit regeneration, drive fibrosis, and promote accrual of macrophages. Whether SCs adversely affect the reparative function of renal macrophages and whether this can be overcome therapeutically to improve repair remains unclear. Here, we demonstrate that increased numbers of macrophages occur alongside SCs in injured kidneys from elderly human patients, and these SC-associated macrophages are pro-inflammatory, express lower levels of phagocytic receptor MerTK and have corresponding lower phagocytic ability. Senolytic treatment promotes an anti-inflammatory macrophage phenotype in aged/injured murine kidneys and inhibits fibrosis, while macrophage depletion reduces SCs and fibrosis, and enhances repair. Treatment with Colony-Stimulating Factor (CSF)-1 improves repair by rescuing macrophage MerTK expression and phagocytic function. Our data demonstrate a reciprocal feed-forward loop between SCs and macrophages in the kidney that propagates ongoing renal damage and inflammation and can be overcome by treatment with CSF-1.